Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy Ugandans.
about
Reference intervals in healthy adult Ugandan blood donors and their impact on conducting international vaccine trialsA phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in AfricaRepeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefitPhase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidateFc receptor-mediated antiviral antibodies.Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization.Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individualsTiming of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects.Optimization of HIV-1 Envelope DNA Vaccine Candidates within Three Different Animal Models, Guinea Pigs, Rabbits and Cynomolgus MacaquesHIV DNA Vaccine: Stepwise Improvements Make a Difference.Sex and Urbanicity Contribute to Variation in Lymphocyte Distribution across Ugandan PopulationsPhase I study of a herpes simplex virus type 2 (HSV-2) DNA vaccine administered to healthy, HSV-2-seronegative adults by a needle-free injection system.HIV-specific antibody-dependent cellular cytotoxicity: a novel vaccine modality.HIV Susceptibility of human antigen-specific CD4 T cells in AIDS pathogenesis and vaccine response.
P2860
Q28474276-41B11EFE-9090-4118-A032-48E8A4E2A103Q28741673-83F4F46F-EB3B-409F-A16F-EC4E6C92DCAAQ28749224-011D9B03-6B7B-4451-AA25-28985ACF0AE8Q33698152-E2F899EC-EC44-4C75-B880-E66B8DEB8A0BQ33749950-AB0BABB2-5460-4281-89FF-B5DAA7055B72Q33899181-B848DF89-4861-418B-A1C5-B1F81BE1B9C3Q34099837-B38AE629-23D8-442E-9FA3-7D8DFDEBC75AQ34218500-F4C8EE71-D182-4ACB-944C-9F50BC940CE1Q35567414-7B7DBE3C-5A9F-4700-A334-7EE42DD48C34Q35826692-43CA83CC-654D-4263-AB4B-CCE3D080EDB9Q35826742-B992C652-B457-47C0-A121-1DC8E75E10C0Q35885093-2642DA61-46D5-4397-9550-270B64ECEE80Q36974311-433E4C07-3C48-4C66-9A53-074D2964B09AQ38061191-A4A2EC04-43F1-46B5-9982-ED408B758A47Q40057846-BF2D098F-E3B2-4E0D-A35F-20F15DABF7D2
P2860
Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy Ugandans.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Induction of HIV-specific func ...... candidate in healthy Ugandans.
@en
type
label
Induction of HIV-specific func ...... candidate in healthy Ugandans.
@en
prefLabel
Induction of HIV-specific func ...... candidate in healthy Ugandans.
@en
P2093
P50
P1433
P1476
Induction of HIV-specific func ...... candidate in healthy Ugandans.
@en
P2093
Benson J Ouma
Chitraporn Karnasuta
Hannah Kibuuka
Leigh Anne Eller
Lynee Galley
Marc S Opollo
Mark S de Souza
Michael A Eller
Peter O Oballah
Silvia Ratto Kim
P304
P356
10.1016/J.VACCINE.2007.08.056
P407
P577
2007-09-17T00:00:00Z